4-Chlor-thioformanilid | 26060-33-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-Chlor-thioformanilid
• 英文别名: p-Chlorthioformanilid；NoName_353；N-(4-chlorophenyl)methanethioamide
• CAS: 26060-33-3
• 化学式: C₇H₆ClNS
• 分子量: 171.65
• InChiKey: LXNCVESUIUIQBH-UHFFFAOYSA-N

物化性质

• 沸点：
  248.4±42.0 °C(Predicted)
• 密度：
  1.362±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  44.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-Chlor-thioformanilid 在 sodium azide 、 四氯化硅 作用下， 以 乙腈 为溶剂， 反应 6.0h， 以92%的产率得到1-(4-氯苯基)-1H-四唑
  参考文献：
  名称：

  Efficient Uncatalyzed Conversion of Primary and Secondary Thioamides into 1-Substituted, 5-Substituted, 1, 5-Disubstituted and Annulated Tetrazoles

  摘要：

  DOI：

  10.1080/10426507.2011.586385
• 作为产物：
  描述：

  4-氯异硫氰酸苯酯 在 二甲基亚砜 作用下， 以 水 为溶剂， 以95%的产率得到4-Chlor-thioformanilid
  参考文献：
  名称：

  Fe₃O₄@GlcA@Cu-MOF: A Magnetic Metal–Organic Framework as a Recoverable Catalyst for the Hydration of Nitriles and Reduction of Isothiocyanates, Isocyanates, and Isocyanides

  摘要：

  A novel magnetic metal-organic framework (Fe₃O₄@GlcA@Cu-MOF) has been prepared and characterized by spectroscopic, microscopic, and magnetic techniques. This magnetically separable catalyst exhibited high catalytic activity for nitrile hydration and the ability to reduce isothiocyanates, isocyanates, and isocyanides with excellent activity and selectivity without any additional reducing agent.

  DOI：

  10.1021/acscombsci.0c00178

文献信息

• OPTICAL RECORDING MEDIUM AND AZO METAL CHELATE COMPOUND
  申请人：Mitsui Chemicals, Inc.

  公开号：EP1997856A1

  公开（公告）日：2008-12-03

  The present invention is to provide an optical recording medium which is capable of performing good recording and reproducing by using a laser having a wavelength of 300 to 900 nm, a novel azo metal chelate compound, and a novel azo compound. Furthermore, the present invention is to provide an optical recording medium having an azo metal chelate compound in a recording layer.

  本发明提供了一种光记录介质，通过使用波长为300至900纳米的激光、一种新型偶氮金属螯合物和一种新型偶氮化合物，能够进行良好的记录和再现。此外，本发明提供了一种在记录层中含有偶氮金属螯合物的光记录介质。
• [EN] SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF<br/>[FR] DERIVE D'ACIDE ARYLALCANOIQUE SUBSTITUE ET SON UTILISATION
  申请人：ASAHI KASEI PHARMA CORP

  公开号：WO2005016862A1

  公开（公告）日：2005-02-24

  A compound represented by the formula (I)[In the formula, Link represents a saturated or unsaturated straight hydrocarbon chain having 1 to 3 carbon atoms, C2 to C6 in the aromatic ring (E) independently represent a ring-constituting carbon atom, one of the ring-constituting carbon atoms may be replaced with V, V represents nitrogen atom, or carbon atom substituted with Zx, Zx represents a saturated alkyl group having 1 to 4 carbon atoms and the like, Rs represents -D-Rx etc., D represents a single bond, oxygen atom and the like, Rx represents a saturated alkyl group having 3 to 8 carbon atoms and the like, AR represents a partially unsaturated or completely unsaturated condensed bicyclic carbon ring or a heterocyclic ring, and Y represents hydrogen atom, a lower alkyl group having 1 to 4 carbon atoms and the like] or a salt thereof. A compound having prostaglandin production-suppressing action and leukotriene production-suppressing action is provided.

  化合物的化学式为（I）。在该式中，Link代表一个由1至3个碳原子组成的饱和或不饱和直链烃链，芳环（E）中的C2至C6独立代表构成环的碳原子，构成环的碳原子中的一个可以被V取代，V代表氮原子，或者被Zx取代的碳原子，Zx代表由1至4个碳原子组成的饱和烷基基团等，Rs代表-D-Rx等，D代表单键、氧原子等，Rx代表由3至8个碳原子组成的饱和烷基基团等，AR代表部分不饱和或完全不饱和的紧凑双环碳环或杂环，Y代表氢原子、由1至4个碳原子组成的低烷基基团等，或其盐。提供了一种具有抑制前列腺素产生和抑制白三烯产生作用的化合物。
• Amine derivative compounds
  申请人：SANKYO COMPANY, LIMITED

  公开号：US20030078426A1

  公开（公告）日：2003-04-24

  An amine compound of the formula (I): 1 wherein R 1 represents an optionally substituted carbamoyl group, etc., R 2 represents a hydrogen atom, etc., R 3 represents a C 1 -C 10 alkyl group etc., W 1 , W 2 and W 3 are the same or different and each represent a single bond or a C 1 -C 8 alkylene group, X, Y and Q represent a sulfur atom, etc., Z represents a ═CH— group, etc., Ar represents a benzene ring, etc. and L represents a hydrogen atom, etc., or a pharmacologically acceptable salt thereof. These compounds are useful in the treatment and/or prophylaxis of diseases such as diabetes, hyperlipemia, arteriosclerosis, cancer, etc.

  化合物的结构式（I）如下：其中R1代表可选择取代的氨基甲酰基团，R2代表氢原子等，R3代表C1-C10烷基等，W1、W2和W3相同或不同，每个代表单键或C1-C8烷基链，X、Y和Q代表硫原子等，Z代表═CH—基团等，Ar代表苯环等，L代表氢原子等，或其药理学上可接受的盐。这些化合物在治疗和/或预防糖尿病、高脂血症、动脉硬化、癌症等疾病方面具有用处。
• Design and Synthesis of Novel Ibuprofen Derivatives as Selective COX-2 Inhibitors and Potential Anti-Inflammatory Agents: Evaluation of PGE2, TNF-α, IL-6 and Histopathological Study
  作者：Hala Bakr El-Nassan、Peter Amir Halim、Yara Sayed El-Dash

  DOI：10.2174/1573406417666210809162636

  日期：2022.5

  ibuprofen derivatives were synthesized starting from ibuprofen. Their chemical structure was confirmed by spectral data. All the compounds were tested for their COX inhibitory activity. RESULTS The best COX-2 activity and selectivity were obtained with compounds 5c and 5d, which were subjected to further in vivo testing (carrageenan-induced paw edema, rat serum PGE2, TNF- α and IL-6, hot plate latency test)

  背景报道布洛芬在COX-2结合位点的结合方式表明，羧基在环氧合酶通道入口处与Arg-120和Tyr-355结合，不会延伸到口袋中。这解释了布洛芬的非选择性。基于这一事实，我们假设延长布洛芬中羧酸部分的长度并添加更多的大体积刚性基团以及带有氢键功能的大体积基团可能会增加布洛芬的选择性并减少副作用，同时保持其镇痛和抗炎活性。目的在这项工作中，设计和制备了四个系列的布洛芬衍生物。这些化合物是通过增加羧酸酯基团的长度以及大疏水基团的结合来设计的。方法以布洛芬为原料合成了四个系列的布洛芬衍生物。它们的化学结构由光谱数据证实。测试所有化合物的COX抑制活性。结果化合物 5c 和 5d 获得了最佳的 COX-2 活性和选择性，并对其进行了进一步的体内试验（角叉菜胶诱导的爪水肿、大鼠血清 PGE2、TNF-α 和 IL-6、热板潜伏期试验）研究它们的抗炎和镇痛活性以及它们对胃粘膜的影响。两种化合物的抗炎活
• Syntheses, in vitro urease inhibitory activities of urea and thiourea derivatives of tryptamine, their molecular docking and cytotoxic studies
  作者：Kanwal、Majid Khan、Arshia、Khalid Mohammed Khan、Shahnaz Parveen、Muniza Shaikh、Narjis Fatima、M. Iqbal Choudhary

  DOI：10.1016/j.bioorg.2018.10.070

  日期：2019.3

  and OCH3 substituents at aryl part were the most potent derivatives. Compound 14 (IC50 = 11.4 ± 0.4 μM) with a methyl substituent at ortho position was found to be the most active member of the series. Whereas, among halogen substituted derivatives, para substituted chloro compound 16 (IC50 = 13.7 ± 0.9 μM) showed good urease inhibitory activity. These synthetic derivatives were found to be non-cytotoxic

  脲酶是酰胺水解酶家族的一种酶，可引起人体的各种病理状况，包括消化性溃疡，导管结壳，肾结石形成，肝昏迷，脑病等。因此，近年来寻找有效的脲酶抑制剂引起了科学上的重大关注。通过使色胺与不同的取代苯基异氰酸酯/异硫氰酸酯反应，合成了色胺的尿素和硫脲衍生物（1 – 25）。评估了合成化合物的脲酶抑制活性，在（IC 50）范围内对脲酶表现出良好的抑制潜力。 与标准硫脲（IC 50  = 21.2 ±1.3μM）相比，= 11.4±0.4–24.2±1.5μM ）。在25种化合物中，发现14种比标准化合物更具活性。有限的结构活性关系表明，在芳基部分具有CH 3和OCH 3取代基的化合物是最有效的衍生物。发现 在邻位带有甲基取代基的化合物14（IC 50 = 11.4±0.4μM）是该系列中最活跃的成员。而在卤素取代的衍生物中，对位取代的氯化合物16（IC 50 = 13.7±0.9μM）表现出良好的脲酶